Synthetic Cathinones (Bath Salts): An Emerging Domestic Threat
Synthetic Cathinones (Bath Salts): An Emerging Domestic Threat
Synthetic Cathinones (Bath Salts): An Emerging Domestic Threat
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Synthetic</strong> <strong>Cathinones</strong> (<strong>Bath</strong> <strong>Salts</strong>): <strong>An</strong> <strong>Emerging</strong> <strong>Domestic</strong> <strong>Threat</strong>29. Centers for Disease Control, Morbidity and Mortality Weekly Report, “Emergency Department Visits AfterUse of a Drug Sold as “<strong>Bath</strong> <strong>Salts</strong>”—Michigan, November 13, 2010-March 31, 2011.30. Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Prevention(CSAP), Division of Workplace Programs, “‘SAMHSA-certified’ Laboratories versus ‘NIDA-certified’Laboratories,” , April 2006, accessed March 2,2011; SAMHSA CSAP Division of Workplace Programs, “Identify Issues: Test for Drug Use.” , accessed March 2, 2011.31. Division of Workplace Programs, “<strong>An</strong>alytical Testing Methods,” , February 2005, accessed March 2, 2011.32. Redwood Toxicology Laboratory, Press Release, , January 18, 2011, accessed March 2, 2011.33. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Advisory Council on the Misuse ofDrugs (AMCD), “Consideration of the <strong>Cathinones</strong>,” March 31, 2010.34. DEA Media Roundtable on <strong>Synthetic</strong> Drugs, February 16, 2011.35. FDA, Guidance for Industry: Street Drug Alternatives, March 2000, , accessed March 2, 2011.36. FDA, Guidance for Industry: Street Drug Alternatives, March 2000, , accessed March 2, 2011.37. FDA, Guidance for Industry: Street Drug Alternatives, , March 2000, accessed March 2, 2011.38. NAMSDL, “Table of Cathinone and Cathinone Derivatives: Bills, Statutes, and Regulations,” May 13, 2011.39. NAMSDL, “Table of Cathinone and Cathinone Derivatives: Bills, Statutes, and Regulations,” May 13, 2011.40. Department of the Air Force, Headquarters Air Force Special Operations Command, “General Order Prohibitingthe Use of Intoxicating Substances, ,January 29, 2010, accessed March 2, 2011; Department of the Navy, Nuclear Weapon Personal ReliabilityProgram, DON NW PRP Newsletter, ,January 20, 2011, accessed March 2, 2011; Department of the Navy, “Drug Abuse ZeroTolerance Policy and Prohibition on Possession of Certain Substances,” , March 25, 2010, accessed on March 2, 2011; Department of the Army, “Prohibiting Useof lntoxicating Substances (CG Policy #0-21),” , August 12, 2010, accessed on March 2, 2011.41. United Kingdom Advisory Council on the Misuse of Drugs, “Consideration of the <strong>Cathinones</strong>,”,March 31, 2010, accessed on March 2, 2011.42. Redwood Toxicology Laboratory, Press Release, “Redwood Toxicology Laboratory <strong>An</strong>nounces Oral Fluid Testfor <strong>Synthetic</strong> Cannabinoids: JWH-018, JWH-073 and JWH-250,” , November 15, 2010.43. David M. Wood, et al., “Recreational Use of Mephedrone (4-Methylmethcathine, 4-MMC) with AssociatedSympathomimetic Toxicity,” The Journal of Medical Toxicology, published online April 1, 2010.44. EMCDDA, Europol, Risk Assessment Report of a new psychoactive substance: 4-methylmethcathinone(mephedrone), , September 2010, accessed onMarch 2, 2011.45. David M. Wood, et al., “Recreational Use of Mephedrone (4-Methylmethcathine, 4-MMC) with AssociatedSympathomimetic Toxicity,” The Journal of Medical Toxicology, published online April 1, 2010.46. Westphal, F., et al., “Mass and NMR Spectroscopic Characterization of 3,4-methylenedioxypyrovalerone: ADesigner Drug With a-Pyrolidinophenone Structure,” Forensic Science International, 2009.47. P. Deniker, “Abuse of Pyrovalerone in Drug Addicts,” <strong>An</strong>nales Medico-Psychologiques, November 1975.14
Change language